Melanoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Melanoma stocks.

Melanoma Stocks Recent News

Date Stock Title
Oct 2 BMY STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
Oct 2 PDSB PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation
Oct 2 CSTL Castle Biosciences Hosts Groundbreaking Ceremony at Site of New Corporate Headquarters in Friendswood, Texas
Oct 1 MYGN Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
Oct 1 BMY PRME Stock Rises 11.8% on Collaboration With Bristol Myers
Oct 1 BMY A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
Oct 1 MYGN BMRN or MYGN: Which Is the Better Value Stock Right Now?
Oct 1 BMY BMS and Prime ink potential $3.5bn deal to develop T cell therapies
Oct 1 BMY Read This Before Considering Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming US$0.60 Dividend
Oct 1 BCAB BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress
Oct 1 BMY 5 FDA decisions to watch in the fourth quarter
Oct 1 BMY Bristol-Myers Squibb Company (BMY) is Driving Growth Through Strategic Acquisitions
Sep 30 BMY Bristol Myers gets $6.4B Celgene CVR case dismissed: report
Sep 30 BMY Sector Update: Health Care Stocks Advance Late Afternoon
Sep 30 BMY US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals
Sep 30 BMY Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Sep 30 BMY Prime Medicine stock rallies 15% on Bristol Myers deal, drug updates
Sep 30 BMY Bristol, Prime Medicine in deal to develop T-cell therapies
Sep 30 BMY Company News for Sep 30, 2024
Sep 30 BMY Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
Melanoma

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.The primary cause of melanoma is ultraviolet light (UV) exposure in those with low levels of skin pigment. The UV light may be from either the sun or from other sources, such as tanning devices. About 25% develop from moles. Those with many moles, a history of affected family members, and who have poor immune function are at greater risk. A number of rare genetic defects such as xeroderma pigmentosum also increase risk. Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous.Using sunscreen and avoiding UV light may prevent melanoma. Treatment is typically removal by surgery. In those with slightly larger cancers, nearby lymph nodes may be tested for spread. Most people are cured if spread has not occurred. For those in whom melanoma has spread, immunotherapy, biologic therapy, radiation therapy, or chemotherapy may improve survival. With treatment the five-year survival rates in the United States is 98% among those with localized disease and 17% among those in whom spread has occurred. The likelihood that it will come back or spread depends how thick the melanoma is, how fast the cells are dividing, and whether or not the overlying skin has broken down.Melanoma is the most dangerous type of skin cancer. Globally, in 2012, it newly occurred in 232,000 people. In 2015 there were 3.1 million with active disease which resulted in 59,800 deaths. Australia and New Zealand have the highest rates of melanoma in the world. There are also high rates in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America. Melanoma is more common in men than women. Melanoma has become more common since the 1960s in areas which are mostly populated with white people.

Browse All Tags